ClinConnect ClinConnect Logo
Search / Trial NCT03093194

Vaginal Antimicrobacterial Preparation Before Cesarean Secation for Endometritis Prevention

Launched by RAMBAM HEALTH CARE CAMPUS · Mar 22, 2017

Trial Information

Current as of July 04, 2025

Unknown status

Keywords

ClinConnect Summary

BACKGROUND In the last decades, caesarean sections rate have escalated steadily worldwide. In 2013, more than 32.7% births in the United States were by cesarean section 1. These high rates of cesarean deliveries are of substantial concern due to the potential associated complications such as endometritis (6-11%) 2, wound complications (1-2%) 2, hemorrhage, injury to pelvic organs (0.2-0.5%)2, and thromboembolic disorders (100-240 per100,000) 3 .

One of the common complications following CS is endometritis. Post cs endometritis prolongs the patient hospitalization therefore not only elevati...

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • an elective or emergent CS in a woman who did not report having a fever or skin infection signs in the 5 days prior to surgery.
  • Exclusion Criteria:
  • 1. a known allergy to antiseptic soap, chlorohexidine-alcohol or shellfish
  • 2. women who had any infection in the perioperative period.

About Rambam Health Care Campus

Rambam Health Care Campus is a leading medical institution located in Haifa, Israel, renowned for its comprehensive patient care, advanced research initiatives, and commitment to medical education. As a prominent clinical trial sponsor, Rambam is dedicated to advancing healthcare through innovative research and development, facilitating a wide range of clinical studies across various therapeutic areas. The campus boasts state-of-the-art facilities, a multidisciplinary team of expert researchers and clinicians, and a robust infrastructure that supports rigorous scientific inquiry and ethical standards in clinical trials. By fostering collaboration and leveraging cutting-edge technology, Rambam Health Care Campus aims to enhance treatment options and improve patient outcomes globally.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials